Association between Foot Growth and Musculoskeletal Loading in Children with Prader-Willi Syndrome before and during Growth Hormone Treatment

被引:8
作者
Eiholzer, Urs [1 ]
Meinhardt, Udo [1 ]
Gallo, Chiara [1 ]
Schlumpf, Michael [1 ]
Rousson, Valentin [2 ]
L'Allemand, Dagmar [1 ]
机构
[1] Ctr Pediat Endocrinol Zurich, Zurich, Switzerland
[2] Univ Lausanne, Inst Social & Prevent Med, Stat Unit, Lausanne, Switzerland
关键词
X-RAY ABSORPTIOMETRY; BODY-COMPOSITION; DUTCH CHILDREN; THERAPY; LENGTH; MASS; HAND;
D O I
10.1016/j.jpeds.2008.08.008
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective To explore how foot growth relates to musculoskeletal loading in children with Prader-Willi syndrome (PWS). Study design In 37 children with PWS, foot length (FL) before and after 6 years of growth hormone therapy (GHT) was retrospectively evaluated with parental and sibling's FL, height, and factors reflecting musculoskeletal loading, such as weight for height (WfH), lean body mass (LBM: dual energy X-ray absorptiometry, deuterium labeled water), physical activity (accellerometry). and walk age. Because of the typically biphasic evolution of body mass and the late walk age in PWS, 2 age groups were separated (group 1, >2.5 years. group 2, <= 2.5 years). Results Children with PWS normalized height, but not FL after 6 years of GHT. Parental FL correlation with PWS's FL was lower than with sibling's FL. In group 1, FL positively correlated with WfH, LBM, and physical activity. In group 2, FL negatively correlated with age at onset of independent ambulation. Foot catch-up growth with GHT was slower in group 2 compared with group 1. Conclusion In PWS, FL is positively associated with musculoskeletal loading. Small feet in children with PAN'S before and during long-term GHT maybe more than just mother dysmorphic feature, but may possibly reflect decreased musculoskeletal loading influencing foot growth and genetic and endocrine factors. (J Pediatr 2009,154:225-9)
引用
收藏
页码:225 / 229
页数:5
相关论文
共 24 条
[1]   Head circumference and body proportions before and during growth hormone treatment in short children who were born small for gestational age [J].
Arends, NJT ;
Boonstra, VH ;
Hokken-Koelega, ACS .
PEDIATRICS, 2004, 114 (03) :683-690
[2]   Determinants of body composition measured by dual-energy X-ray absorptiometry in Dutch children and adolescents [J].
Boot, AM ;
Bouquet, J ;
deRidder, MAJ ;
Krenning, EP ;
KeizerSchrama, SMPFD .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1997, 66 (02) :232-238
[3]   Growth hormone normalises height, prediction of final height and hand length in children with Prader-Willi syndrome after 4 years of therapy [J].
Eiholzer, U ;
l'Allemand, D .
HORMONE RESEARCH, 2000, 53 (04) :185-192
[4]   Body composition abnormalities in children with Prader-Willi syndrome and long-term effects of growth hormone therapy [J].
Eiholzer, U ;
l'Alleman, D ;
van der Sluis, I ;
Steinert, H ;
Gasser, T ;
Ellis, K .
HORMONE RESEARCH, 2000, 53 (04) :200-206
[5]   Growth hormone and body composition in children younger than 2 years with Prader-Willi syndrome [J].
Eiholzer, U ;
I'Allemand, D ;
Schlumpf, M ;
Rousson, V ;
Gasser, T ;
Fusch, C .
JOURNAL OF PEDIATRICS, 2004, 144 (06) :753-758
[6]   Improving body composition and physical activity in Prader-Willi Syndrome [J].
Eiholzer, U ;
Nordmann, Y ;
L'Allemand, D ;
Schlumpf, M ;
Schmid, S ;
Kromeyer-Hauschild, K .
JOURNAL OF PEDIATRICS, 2003, 142 (01) :73-78
[7]  
Eiholzer U., 2001, PRADER WILLI SYNDROM
[8]  
Ellis K. J., 2003, Prader-Willi syndrome as a model for obesity. International Symposium, Zurich, Switzerland, 18-19 October, 2002, P49, DOI 10.1159/000072588
[9]  
FUSCH C, 1993, ENV HLTH STUDIES, V29, P125
[10]   REFERENCE VALUES OF ANTHROPOMETRIC MEASUREMENTS IN DUTCH CHILDREN - THE OOSTERWOLDE STUDY [J].
GERVER, WJM ;
DRAYER, NM ;
SCHAAFSMA, W .
ACTA PAEDIATRICA SCANDINAVICA, 1989, 78 (02) :307-313